Speakers
Speakers
Psychological Medicine, University of Newcastle upon Tyne,
Visiting Professor, University de Paris Est, France & Honorary Professor in Psychological Treatments Research, Institute of Psychiatry, London
Presentation:Case Finding Strategies to Augment Early Identification of Bipolar Disorders
Co-Director of the Bipolar Clinic and Research Program
Associate Director of the Depression Clinical and Research Program, Massachusetts General Hospital
Presentation:Doing the Impossible: The Practice of Evidence Based Psychiatry with Bipolar
Chief Executive Officer, Singapore Clinical Research Institute
Professor and Vice-Dean, Duke-NUS Graduate Medical School, Singapore
Department of Psychiatry, Deakin University
Presentation:"Oxidative processes in mood disorders - mechanisms and therapeutics"
Centre for Mental Health Research, The Australian National University
Presentation:"Internet interventions for mood disorders
Brain and Mind Research Institute, University of Sydney
Presentation:"Sleep in mood disorders - mechanisms and therapeutics"
- Professor Gin Malhi
Discipline of Psychiatry, University of Sydney
Presentation:"Brain imaging in mood disorders"
School of Psychiatry, University of New South Wales
Presentation:"Can we identify those at risk for mood disorders?"
Head of Dept, Chair of Primary Care Research, Director of the Primary Care Research Unit, University of Melbourne
Presentation:"Depression in the general practice setting"
Professor and Chair, Department of Psychiatry and Behavioral Medicine, Wake Forest University Health Sciences
Presentation:Quality of Life and Function in Depressed Patients Following ECT
Professor Jan Scott
Professor of Psychological Medicine, University of Newcastle upon Tyne,
Visiting Professor, University de Paris Est, France
& Honorary Professor in Psychological Treatments Research, Institute of Psychiatry, London
Jan Scott is now Professor of Psychological Medicine at the University of Newcastle. She is a Distinguished Founding Fellow of the Academy of Cognitive Therapy (one of 8 individuals worldwide). Her research focuses on combined treatment strategies (using pharmacotherapy and Cognitive Therapy) in the treatment of individuals with bipolar disorders, chronic and/or severe depressions, and treatment resistant schizophrenia. More recently, she has begun to research the development of age appropriate services to meet the needs of adolescents and young adults with early onset bipolar disorders. Additional research focuses on mechanisms of action of psychological treatments, the prediction and management of medication non-adherence and studies of the short- and long-term prognosis of bipolar disorders.
Previous posts include a training scholarship with Professor Aaron T Beck in Philadelphia, USA; The Royal College of Psychiatrists Travelling Fellowship (allowing secondments to University of Wisconsin in Madison and to Johns Hopkin University in Baltimore). Professor Scott has also spent time working with Eugene Paykel in Cambridge, UK and Eduard Vieta and his team in Barcelona, Catalunya.
Dr Andrew Alan Nierenberg
Dr. Nierenberg is Professor of Psychiatry, Harvard Medical School, Co-Director of the Bipolar Clinic and Research Program, and Associate Director of the Depression Clinical and Research Program, Massachusetts General Hospital (MGH). He attended the Albert Einstein College of Medicine of Yeshiva University followed by a residency in psychiatry at New York University/Bellevue Hospital and then became a Robert Wood Johnson Clinical Scholar at Yale University. In 1992, he joined the Psychiatry Department at MGH. He has published over 250 original articles and over 60 reviews, editorials, and chapters, and has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders continuously since 1994. He received the NDMDA Gerald L. Klerman Young Investigator Award and was elected as a member of the American College of Neuropsychopharmacology (ACNP) and as a Distinguished Fellow of the American Psychiatric Association. His primary interests are treatment resistant depression, bipolar depression, and the longitudinal course of mood disorders. Dr. Nierenberg lectures nationally and internationally, teaches and supervises clinicians and researchers, maintains an active clinical practice, conducts clinical trials, and is Editor in Chief of CNS Spectrums as well as on the editorial boards of multiple psychiatric journals.
Dr A. John Rush
Dr Rush is Professor and Vice Dean of Clinical Sciences at Duke-NUS, Singapore and CEO of the Singapore Clinical Research Institute.
His research has focused on the development and testing of innovative treatments for mood disorders including medications, somatic treatments, psychotherapy, and disease management protocols (treatment algorithms). He has authored over 600 papers and chapters and 10 books. He served as PI and Director of the NIMH Depression Trials Network (1999-2010).
His research and teaching awards include those from the American College of Psychiatrists, American Psychopathological Association, Columbia College of Physicians and Surgeons, American Psychiatric Association and Society of Biological Psychiatry.
Professor Michael Berk
Professor Michael Berk is currently appointed as Chair of Psychiatry in the School of Medicine, Deakin University. He also is a Professorial Research fellow at the University of Melbourne and the Mental Health Research Institute, and leads the first episode bipolar program at Orygen Youth Health. He is immediate past President of the International Society of Bipolar Disorders, and Chairman of the Australasian Society of Bipolar Disorders. He has published over 350 papers on a range of topics with his research interests focusing on mood and psychotic disorders, particularly bipolar disorder and depression. His greatest contribution to the field is in the discovery and implementation of novel therapies. He has published over 20 self-initiated, non-industry randomised controlled trials, predominantly in bipolar disorder. He is a past committee member of both the Collegium Internationale Psychopharmacologicum and World Federation of Societies of Biological Psychiatry is a member of a number of international advisory boards. He was the founding editor of The Journal of Depression and Anxiety, is associate editor of both the Australian and New Zealand Journal of Psychiatry and Early Intervention in Psychiatry, has served as guest editor or is on the editorial board of 12 other journals as well as being a reviewer of 30 journals.
He is the recipient of a number of grants, including a NHMRC CCRE and 3 NHMRC project grants, two beyondblue grants and two Stanley Medical Research Institute awards and is a lead investigator on the CRE for Mental Health. He is regularly invited as a speaker at international meetings. In 2008, he was awarded the Australasian Society of Psychiatric Research Eli Lilly Oration, the Pathcare Smart Geelong Research and Learning Expo Health and Lifestyle award and the G Force Recruitment Researcher Of The Year award for this work, and in 2009 received a commendation in the Ministers Award for Mental Health.
Professor Helen Christensen
Helen Christensen is Director of the Centre for Mental Health Research at the Australian National University and a NHMRC Senior Principal Research Fellow. Her broader research area covers Research in Public Health and Research in Mental Health. She is the author of over 300 refereed journal articles, seven consumer books and three open access websites. Her areas of interest include the evaluation of internet applications/ online programs for the prevention and treatment of mental disorders, the quality of websites, the integration of new technologies into health care, the development of evidence- informed policy and methods to measure impact and dissemination. Helen holds a PhD from The University of New South Wales, a Master of Psychology (Honours, 1st Place) from The University of New South Wales and a Bachelor of Arts (Honours) from The University of Sydney.
Professor Ian Hickie
UNIVERSITY OF SYDNEYFrom 2000 to 2003 Professor Hickie was CEO of beyondblue: the national depression initiative, and from 2003-2006 he served as its Clinical Advisor. In 2003, he was appointed as the Executive Director of the Brain & Mind Research Institute (BMRI).
In 2006, Professor Hickie received the Australian Honours Award of Member (AM) in the General Division; for services to medicine in the development of key national mental health initiatives and general practice services in both the public and non-government sectors. In October of that same year, the Australian Financial Review included Professor Hickie in its list of the top 10 cultural influences. The specific comments noted his role as a “long-term campaigner”, “the person who orchestrated the campaign” that led to the COAG announcements ($4 billion dollars over five years).
Professor Hickie was appointed to the Prime Minister’s Australian National Council on Drugs from 2007 to 2011, and has led the BMRI as a founding member of the new National Youth Mental Health Foundation (‘headspace’). Also in this year, Professor Hickie was elected as a Fellow of the Academy of the Social Sciences in Australia.
From 2008-2013, he is one of the first round of new NHMRC 2008 Australian Fellows. In July 2008 he was appointed to the Federal Health Minister’s new National Advisory Council on Mental Health. In November 2009, Professor Hickie received the Research Australia national advocacy award for his work in mental health. In 2011 he was appointed to the Mental Health Expert Working Group (MHEWG), Department of Health and Ageing.
Professor Philip Mitchell
Philip Mitchell AM, MB BS (Hons I), MD, FRANZCP, FRCPsych is Scientia Professor and Head of the School of Psychiatry at the University of New South Wales in Sydney, Australia; Convenor of Brain Sciences UNSW; Consultant Psychiatrist, Prince of Wales Hospital; Director, Bipolar Disorders Clinic, Black Dog Institute, Sydney; Guest Professor, Shanghai Jiaotong University; Member of the NHMRC Academy; Board Member of the Black Dog Institute; and Board Member of the Anika Foundation for Adolescent Depression and Suicide.
His research and clinical interests are in bipolar disorder and depression, with a particular focus on: molecular genetics of bipolar disorder; predictors of the development of bipolar disorder in at-risk individuals; pharmacological and psychological treatments for bipolar disorder and depression; clinical phenomenology of bipolar disorder and depression; and stimulatory therapies for depression (such as transcranial magnetic stimulation and direct current stimulation). Professor Mitchell has published (in conjunction with colleagues) over 370 peer-reviewed papers or book chapters on these topics and is a member of an Australian NHMRC-funded Program Grant on depression and bipolar disorder. He is an associate editor of 'Therapeutic Advances in Chronic Disease' and 'Neuropsychiatry', and also serves on the editorial boards of 'Psychiatric Genetics', 'CNS Drugs', 'CNS Spectrums', 'Current Therapeutic Research', 'Therapeutic Advances in Psychopharmacology' and 'Medicine Today'.
In 2002 Prof. Mitchell was awarded the Senior Research Award of the Royal Australian and New Zealand College of Psychiatrists. In 2004, he received the Founders Medal of the Australasian Society for Psychiatry Research. In 2006, he received a Medical Media award from Research Australia for his media commentary on a wide range of mental health issues. In 2008, he received a Rotary International Vocational Excellence Award which recognizes outstanding contributions made by individuals or teams for significant advancement in their field in Australia. In 2008, he was invited to give the endowed Samuel Novey Lecture in Psychological Medicine at Johns Hopkins University, Department of Psychiatry and Behavioral Sciences. In 2010, he was elected as a Councillor of the international organization CINP (Collegium Internationale Neuro-Psychopharmacologicum). In the 2010 Australia Day honours list Professor Mitchell was appointed as a Member of the Order of Australia for service to medical education, particularly in the field of psychiatry, as an academic, researcher and practitioner, through contributions to the understanding, treatment and prevention of mental illnesses.
Professor Jane Gunn
Prof Jane Gunn is the inaugural Chair of Primary Care Research and Head of the Department of General Practice at The University of Melbourne. A general practitioner, her current research interests include depression and related disorders and the complex interplay between emotional well-being, physical health and illness. She leads the mental health research program within the Primary Care Research Unit (PCRU) at The University of Melbourne.
She serves on a number of professional committees in relation to general practice and mental health such as: the NHMRC Research Committee, NHMRC Borderline Personality Group Guideline Development Committee, beyondblue Victorian Centre of Excellence, National Prescribing Service Program Evaluation and Research Advisory Group, Steering Committee for the National Survey of Mental Health and Wellbeing; and Past President of the Australian Association for Academic General Practice. In 2009, she was made Visiting Professor of the Scottish School of Primary Care, University of Edinburgh, UK.
In 2008 Prof Gunn was the inaugural recipient of the Bridges-Webb Medal for exceptional contribution to general practice research awarded by the Australian Association for Academic General Practice.
Professor Vaughn McCall
Dr. McCall is presently Professor and Chairman of the Department of Psychiatry and Behavioral Medicine at the Wake Forest University School of Medicine. He completed his medical degree and post-graduate psychiatric training at Duke University. He completed a Masters degree in Epidemiology from Wake Forest University. He is board certified in general psychiatry, geriatric psychiatry, and sleep disorders medicine. His research interests include depression, electroconvulsive therapy, quality of life, and insomnia. His research has been continuously funded by the National Institute of Mental Health since 1995, and he is author of more than 300 publications, including more than 140 peer-reviewed journal articles. He is Editor of the Journal of ECT, Past President of the Association for Convulsive Therapy, and a prior Director of the Board of the American Academy of Sleep Medicine. His awards have included The Thomas Ball Award, presented by the Chesapeake Bay Sleep Society for service in Sleep Medicine, and the Eugene Hargrove Award given by the NC Psychiatric Association for achievement in psychiatric research, and the Honored Speaker Award given by the International Association of ECT and Neurostimulation.
Call For Symposia
Submission Instructions
- Submit a brief 100-word synopsis of the symposium indicating the key areas to be covered, plus the speakers and chairperson details.
- Ensure that your list of speakers come from a wide geographical area (not all from one institution).
- Indicate whether or not you have approached your speakers in advance of your submission.
- The submission deadline has been extended to Friday 29th July 2011.
- You will receive notification of the outcome on Monday 15th August 2011.
- Unfortunately, there is no sponsorship available for those speaking in symposia.
If you have any enquiries regarding submission of symposium proposals, please contact:
ASBD 2011 c/o Meeting Office
ICMS Pty Ltd
Phone: +61 3 9682 0244
Email: asbd2011@icms.com.au